UnitedHealth Aktie
| 509,90USD | -0,69USD | -0,14% |
WKN: 869561 / ISIN: US91324P1021
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99,77 |
| The Vanguard Group, Inc. | 9,11 |
| Vanguard Group, Inc. (Subfiler) | 8,79 |
| State Street Corp. | 4,95 |
| Vanguard Total Stock Market ETF | 3,15 |
| Capital Research & Management Co. (World Investors) | 2,85 |
| BlackRock Fund Advisors | 2,79 |
| Vanguard 500 Index Fund | 2,70 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 2,57 |
| Wellington Management Co. LLP (Wellington Breakout) | 2,53 |
| Fidelity Management & Research Co. LLC | 2,46 |
| BlackRock Institutional Trust Co. NA | 2,19 |
| Geode Capital Management LLC | 2,13 |
| Capital Research & Management Co. (Global Investors) | 1,95 |
| Capital Research & Management Co. (International Investors) | 1,60 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 330 000 | 350 000 | 400 000 | 440 000 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,78 | 0,82 | 0,81 | 0,84 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 53 718 | 61 758 | 69 069 | 78 437 | 85 779 |
| Summe Anlagevermögen | 146 962 | 153 996 | 181 233 | 199 978 | 212 499 |
| Summe Aktiva | 200 680 | 215 754 | 250 302 | 278 415 | 298 278 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 130 141 | 139 275 | 163 955 | 179 496 | 0 |
| Summe Eigenkapital | 70 539 | 76 479 | 86 347 | 98 919 | 0 |
| Summe Passiva | 200 680 | 215 754 | 250 302 | 278 415 | 298 278 |
Adresse
| 9900 Bren Road East, 55343 Minnetonka | |
| Telefon | +1 (800) 328-5979 |
| Fax | +1 (800) 936-1819 |
| Internet | http://www.unitedhealthgroup.com |
Management
|
Andrew Philip Witty
Chief Executive Officer & Director |
|
Brett Manderfeld
Senior VP-Capital Markets Communications Area |
|
Charles D. Baker
Independent Director |
|
Chris Zaetta
Secretary, Chief Legal Officer & Executive VP |
|
D. Ellen Wilson
Executive Vice President |
|
Dame Vivian Hunt
Chief Innovation Officer |
|
Daniel J. Schumacher
Chief Strategy & Growth Officer |
|
Deedrea Grein
Vice President-Corporate Strategy |
|
Frances Jacobs
Senior Vice President-Investor Relations |
|
Frederick William McNabb
Independent Director |
|
John Franklin Rex
President & Chief Financial Officer |
|
John H. Noseworthy
Independent Director |
|
John Walthour
Vice President-Strategic Insights |
|
Joy Fitzgerald
SVP, Chief Diversity, Equity & Inclusion Officer |
|
Kristen L. Gil
Independent Director |
|
Kristi Hummel
Chief Talent Officer |
|
Kuai H. Leong
Deputy Secretary & Senior Deputy General Counsel |
|
Larry C. Renfro
Vice Chairman |
|
Margaret-Mary Wilson
Chief Medical Officer & Executive Vice President |
|
Michele J. Hooper
Lead Independent Director |
|
Patricia L. Lewis
Chief Sustainability Officer & Executive VP |
|
Paul R. Garcia
Independent Director |
|
Richard J. Mattera
Chief Development Officer & Senior Vice President |
|
Richard J. Migliori
Executive Vice President |
|
Rupert Mark Boden Bondy
Senior Counsel, EVP-Governance & Compliance |
|
Sandeep Dadlani
Chief Digital & Technology Officer & EVP |
|
Stephanie L. Fehr
Chief Human Capital Officer & EVP-UnitedHealthcare |
|
Stephen J. Hemsley
Chairman |
|
Terry M. Clark
Chief Customer & Marketing Officer & Executive VP |
|
Thomas Edward Roos
Chief Accounting Officer & Executive VP |
|
Timothy Patrick Flynn
Independent Director |
|
Todd Walthall
Executive Vice President-Enterprise Growth |
|
Valerie C. Montgomery Rice
Independent Director |
|
Zack Sopcak
Senior Vice President-Investor Relations |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
